6 112 flow, we collected the majority of this data in the horizontal geometry. However, vertical 113 experiments revealed similar phenomena, viz. the slowed transit of deoxygenated sickle blood and 114 the formation of a dense cap behind the meniscus. The vertical transits were also longer than the 115 horizontal (e.g. ~15 s vertical vs 10 s horizontal). 119 oxygenated blood on the left has clearly gone farther in the same time than the deoxygenated blood 120 on the right. A drop of blood is placed on an 18 mm square coverslip into which a capillary has 121 been inserted. In addition to the blood imbibed into the capillary itself, some blood runs along 122 the space between the capillary and the coverslip, accounting for the odd shape of the source 123 droplet. 143 characterized by a mean and standard deviation, the latter effectively displaying the patient-to-144 patient variation, since there was much less difference between individual replication experiments 145 than seen between different patients. These standard deviations generate the ellipses in Fig. 3 , 146 centered on the mean value we obtained for each genotype. An elliptical zone of paired transit 147 times thus emerged as a characteristic fingerprint of the genotype. For AS blood, only one patient 148 was studied, and that ellipse is taken as a representative value from the other data sets. 180 positive, the remaining distributions other than the genotype in question were integrated outside 181 or inside the dominant region, respectively. As confirmation of this procedure, we generated a 182 large random set of data with a gaussian distribution, using the given means and standard 183 deviations, and found the results computed agreed to within 2 percent. These results are shown 184 in Table 1 , which provides a quantitative measure for what Fig 2 and 200 Since the basis of this test is the difference in the viscosity of sickle blood, we also show how the 201 viscosity varies for the various genotypes. Figure 4a In comparison to such a paper test, the capillary method has 258 similar discrimination, is equally inexpensive, but is dramatically faster since the rise in the 259 capillaries is complete in seconds, not minutes. 267 The fourth test described is a density-based system that does not require cell lysis. [25, 26] 268 Aqueous Multiphase Systems (AMPS) are mixtures of polymers in water that form immiscible 13 269 phases, and have been used with centrifugation with to reveal the presence of high-density cells 270 that are a hall-mark of sickle cell disease. Of course, the method would not distinguish AS from 271 AA, and also might be confounded by things such as liver disease or polycythemia vera that 272 generate denser cells. This system, considered to take 12 minutes, requires the presence of a 273 centrifuge, and given the inefficiency of running a solo tube, would likely mean tests are done in 274 batches.
275 None of these methods match the combination of time resolution inherent in the capillary-based 276 system (20 sec for the two measurements) and its low cost. The cost of the paper-based system 277 might be comparable, but it takes far longer. The polyclonal antibody system is speedy but is 278 still ~6 times slower, and at $5 per test is far more costly than the capillary test. An optimal 279 approach for diagnosis in resource-challenged regions might combine methods. Capillary flow as 280 a pre-screen can rapidly and inexpensively sort AA patients from their sickle counterparts, for 281 whom a follow-up test at higher cost might be appropriate. The value of such a strategy can be 282 appreciated by considering places where the incidence is very high, such as Nigeria. There the S 283 allele appears in about only 20% of the population [4], so that 80% of the tests performed in a 284 general screen would reveal a non-S patient. For other nations with lower incidence, an even 285 greater percentage of tests would be expected to have negative results. For this reason a rapid and 286 inexpensive pre-screen could be very useful.
287 There is also information present in capillary tests that is simply not present in the antibody tests. 292 identical to AA cells; for others it is much more like untreated SS blood. Having a rapid and 293 inexpensive metric that could track such a response could be very useful.
294 An important question is whether the accuracy of the method can be improved. From Fig. 2 it is 295 evident that the patient-to-patient variation is far greater than the variability of measurements on 296 an individual patient. This is dramatically evident in the SC patients. Interestingly, when the 297 measurement was repeated on the same AS patient after several months, the range of variation was 298 virtually identical. We suspect the range of variability in SC and, by extension, AS, is a 299 consequence of the complexity of the sickling process itself. The shapes of the sickled cells can 300 range from the classic, extended eponymous sickle form to compact yet rigid cells that have been 301 said to resemble potatoes.
These shapes are exquisitely sensitive to the rate at which 302 polymerization occurs, [28] which in turn depends on the cellular contents as well as the rate of 303 deoxygenation. In particular, heterozygous conditions produce far greater distortions in the 304 sickled cells than homozygous SS cells, a fact which is utilized in a current drug assay.
[29] The 305 differences within a given genotype might well be the consequence of the history of a given patient 306 that shaped the particular cellular population at the time of observation. While this variable is 307 viewed as confounding in the attempt to ascertain the presence of the S allele, it might actually 308 provide unexpected insights, to the extent that the patients with longer transits might have a more 309 severe course of the disease.
310 In this context, it is a welcome bonus that this test provides a snapshot of patient response to 311 hydroxyurea. Response to this drug has proven to be quite variable.
[27] The last panel of Fig 3   312 demonstrates this, as it is clear that the upper end of the distribution of deoxy transit times contains 313 times equivalent to those of SS patients, suggesting the lack of any significant response to the drug.
314 On the other hand, the low end of the distribution falls decidedly below that of SS patients,
